Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 33 Issue 4
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2015  >  33(4): 370-372

XING Ying, TU Wenlian, LI Jin, ZHEN Jiancun. Analysis of the treatment of AECOPD patient complicated with high-risk case of Pseudomonas aeruginosa and immunocompromised condition[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(4): 370-372. doi: 10.3969/j.issn.1006-0111.2015.04.021
Citation: XING Ying, TU Wenlian, LI Jin, ZHEN Jiancun. Analysis of the treatment of AECOPD patient complicated with high-risk case of Pseudomonas aeruginosa and immunocompromised condition[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(4): 370-372. doi: 10.3969/j.issn.1006-0111.2015.04.021
shu

Analysis of the treatment of AECOPD patient complicated with high-risk case of Pseudomonas aeruginosa and immunocompromised condition

doi: 10.3969/j.issn.1006-0111.2015.04.021
  • 1.

    Department of Pharmacy, Beijing Jishuitan Hospital, Beijing 100035, China

  • 2.

    Department of Clinical Pharmacy, First People's Hospital of Yunnan Province, Kunming 650032, China

  • Received Date: 2014-09-10
  • Rev Recd Date: 2015-03-26
  • Objective To investigate risk factors for Pseudomonas aeruginosa infected AECOPD patients and the significance of immune regulation. Methods The clinical pharmacist is involved in the administration and guardianship of immunocompromised patients with recurrent AECOPD. The clinical pharmacist provides recommendations and theoretical support in antimicrobial drug selection and regulating immunity. Results Clinical pharmacist gave rationalized medication recommendations. It made anti-infective programs more reasonable and effective. Conclusion By assisting physicians in formulating regimens, clinical pharmacists can provide more optimal individualized treatment for patients.
  • [1] 慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组.慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2014年修订版)[J].国际呼吸杂志,2014,34(1):1-11.
    [2] 中华医学会呼吸病学会分会感染学组.铜绿假单胞菌下呼吸道感染诊治专家共识[J].中华结核和呼吸杂志,2014,37(1):9-15.
    [3] 曹雪涛.医学免疫学[M].北京:人民卫生出版社,2009:105-107,149.
    [4] 李 琛,张玲玲,赵洪茹.老年慢性阻塞性肺疾病急性加重期患者细胞免疫功能的变化[J].中国临床研究,2010,23(12):1094-1095.
    [5] 邹 静,刘 斌,陈雪华,等.肺癌患者外周血T 淋巴细胞亚群变化特点及临床意义[J].中国免疫学杂志,2010,26(11):1016-1020.
    [6] Lacedonia D,Salerno FC,Sabato R,et al. Airway cell patterns in patients suffering from COPD and OSAS (overlap syndrome)[J].Respair Med,2011,105(2):303.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(3215) PDF downloads(547) Cited by()

Related
Proportional views

Analysis of the treatment of AECOPD patient complicated with high-risk case of Pseudomonas aeruginosa and immunocompromised condition

doi: 10.3969/j.issn.1006-0111.2015.04.021
  • 1. Department of Pharmacy, Beijing Jishuitan Hospital, Beijing 100035, China
  • 2. Department of Clinical Pharmacy, First People's Hospital of Yunnan Province, Kunming 650032, China
  • Received Date: 2014-09-10
  • Rev Recd Date: 2015-03-26

Abstract: Objective To investigate risk factors for Pseudomonas aeruginosa infected AECOPD patients and the significance of immune regulation. Methods The clinical pharmacist is involved in the administration and guardianship of immunocompromised patients with recurrent AECOPD. The clinical pharmacist provides recommendations and theoretical support in antimicrobial drug selection and regulating immunity. Results Clinical pharmacist gave rationalized medication recommendations. It made anti-infective programs more reasonable and effective. Conclusion By assisting physicians in formulating regimens, clinical pharmacists can provide more optimal individualized treatment for patients.

XING Ying, TU Wenlian, LI Jin, ZHEN Jiancun. Analysis of the treatment of AECOPD patient complicated with high-risk case of Pseudomonas aeruginosa and immunocompromised condition[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(4): 370-372. doi: 10.3969/j.issn.1006-0111.2015.04.021
Citation: XING Ying, TU Wenlian, LI Jin, ZHEN Jiancun. Analysis of the treatment of AECOPD patient complicated with high-risk case of Pseudomonas aeruginosa and immunocompromised condition[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(4): 370-372. doi: 10.3969/j.issn.1006-0111.2015.04.021
shu

    HTML

Reference (6)

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return